Cetirizine hydrochloride
NDC 69729-139, Cetirizine hydrochloride, tablet, from OPMX LLC.
- Product NDC
- 69729-139
- Status
- Listed
- Labeler
- OPMX LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA209274
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69729-139 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CETIRIZINE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69729-139-14 | 69729013914 | 14 TABLET in 1 BOTTLE (69729-139-14) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 69729-139 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69729-139 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69729-139. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.